Skip to content

Supreme LMA Use in Urgent Caesarean Section

Supreme Laryngeal Mask Use in Urgent Caesarean Section

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02026882
Enrollment
584
Registered
2014-01-03
Start date
2013-12-31
Completion date
2015-05-31
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Morbidity

Keywords

Airway, Caesarean

Brief summary

The Supreme Laryngeal Mask Airway (SLMA) is a single use supraglottic device that provides a good seal for positive pressure ventilation and good first attempt insertion rate of 98% in low risk patients undergoing elective Caesarean section. It has a double aperture design that facilitates the introduction of an orogastric tube to aspirate gastric contents. The primary study hypothesis is the first attempt insertion success rate of SLMA use in urgent Caesarean section.

Detailed description

Investigators propose a prospective cohort study to study the first attempt insertion success rate of supreme LMA in general anaesthesia for urgent caesarean section.

Interventions

Supreme Laryngeal Mask Airway. Preoxygenation, rapid sequence induction and cricoid pressure. Induction of general anaesthesia.

Sponsors

KK Women's and Children's Hospital
CollaboratorOTHER_GOV
QuanZhou Women and Children's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 50 years old * American Society of Anesthesiology status 1 or 2 * Weight 40 to 75kg * Normal airway assessment * Term pregnancy (36 weeks or more) * Urgent Caesarean Section

Exclusion criteria

* Body mass index (35 or more) * Difficult airway (Mallampati 4 or abnormal airway assessment) * Gastrooesophageal reflux

Design outcomes

Primary

MeasureTime frameDescription
First attempt insertion success rate1 hourAn attempt is defined as insertion and withdrawal of the device from the patient's airway

Secondary

MeasureTime frameDescription
Aspiration1 hourSigns of aspiration as evidenced by perioperative hypoxaemia, wheezing or crepitations upon auscultation of lungs or postoperative dyspnoea with chest x ray signs of aspiration
blood on SLMA on removal1 hourinspection for presence of blood upon removal of SLMA
Sore throat1 hourSore throat present in recovery room
Time to effective airway placement1 hourInterval from when the device was picked up until appearance of the first end-tidal carbon dioxide waveform
Seal pressure1 hourRecorded by closing the adjustable pressure limiting valve and insufflating the closed breathing system with 3L/min fresh gas flow. The peak circuit airway pressure achieved will be recorded.
Gastric aspirate1 hourVolume of gastric aspirate using gastric tube and pH of gastric aspirate using litmus paper
Neonatal outcomes1 hourNeonatal birthweight. APGAR score. Umbilical venous cord pH
Regurgitation1 hourGastric contents identified in the mouth with pH less than 4

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026